Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2<sup>pos </sup>Ductal Carcinoma in Situ

FENG Zhe; ZHANG Jian; LI Wen-hua; HU Xi-chun; GUO Li-ping

doi:10.12019/j.issn.1671-5144.2018.03.003

FENG Zhe, ZHANG Jian, LI Wen-hua, HU Xi-chun, GUO Li-ping. Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2pos Ductal Carcinoma in Situ[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 137-139. DOI: 10.12019/j.issn.1671-5144.2018.03.003

Citation:

FENG Zhe, ZHANG Jian, LI Wen-hua, HU Xi-chun, GUO Li-ping. Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2pos Ductal Carcinoma in Situ[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 137-139. DOI: 10.12019/j.issn.1671-5144.2018.03.003

Citation:

FENG Zhe, ZHANG Jian, LI Wen-hua, HU Xi-chun, GUO Li-ping. Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2pos Ductal Carcinoma in Situ[J]. Journal of Evidence-Based Medicine, 2018, 18(3): 137-139. DOI: 10.12019/j.issn.1671-5144.2018.03.003

Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2^posDuctal Carcinoma in Situ

Graphical Abstract

Abstract

FullText(HTML)

References (14)

Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2pos Ductal Carcinoma in Situ

Catalog

Export File

Citation

Format

Content

Safety and Efficacy Evaluation of HER2 Peptide-Pulsed Dendritic Cell Vaccine in Preoperative Treatment of Patients with HER2^posDuctal Carcinoma in Situ